Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129222) titled 'Clinical study on the safety and efficacy of allogeneic human bone marrow mesenchymal stem cells in the treatment of sarcopenia-osteoporosis syndrome in the elderly' on Aug. 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Guangzhou First People's Hospital
Condition:
Sarcopenia-osteoporosis syndrome
FB83.1Z
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-08-10
Target Sample Size: Experimental group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319562
Published by HT Digital Content Service...